Abstract
Hepatocellular carcinoma (HCC) with more than 700,000 deaths every year is the most prevalent type of liver cancer and a global concern. It is the fifth most common cancer worldwide and has a poor general prognosis. Chronic hepatitis B virus (HBV) infection is a major cause of HCC. The HBV-infected individual has 100 times higher risk of developing HCC. The x protein of HBV (HBx) has been shown to involve in the development of HCC. In this study, the association between HBV replication and the host cell metabolism is investigated. HepG2 cells are transfected with different genotypes of HBx and total proteins are extracted and analyzed using LC-MS/MS. Our proteomics results indicates that a number of glycolytic enzymes including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase (PK), Phosphoglyceratekinase (PGK) and Lactate dehydrogenase (LDH) are significantly up-regulated in HepG2 cells transfected by HBx comparing with control group. These findings suggest that HBV replication could alter host cell metabolism by increasing the rate of glycolysis to provide important metabolic requirements for nucleotides, amino acids and lipids synthesis. Hence, our proteomics approach may provide candidate biomarkers to improve the diagnosis of HBVrelated HCC patients.
Keywords: Biomarker, HBV, HBx, HCC, LC-MS/MS, metabolic enzymes, proteomics.
Current Proteomics
Title:Role of HBV Replication in Host Cell Metabolism: A Proteomics Analysis
Volume: 10 Issue: 1
Author(s): Laleh Sadrolodabaee, Tiong Keng Low, Huixing Feng and Wei Ning Chen
Affiliation:
Keywords: Biomarker, HBV, HBx, HCC, LC-MS/MS, metabolic enzymes, proteomics.
Abstract: Hepatocellular carcinoma (HCC) with more than 700,000 deaths every year is the most prevalent type of liver cancer and a global concern. It is the fifth most common cancer worldwide and has a poor general prognosis. Chronic hepatitis B virus (HBV) infection is a major cause of HCC. The HBV-infected individual has 100 times higher risk of developing HCC. The x protein of HBV (HBx) has been shown to involve in the development of HCC. In this study, the association between HBV replication and the host cell metabolism is investigated. HepG2 cells are transfected with different genotypes of HBx and total proteins are extracted and analyzed using LC-MS/MS. Our proteomics results indicates that a number of glycolytic enzymes including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase (PK), Phosphoglyceratekinase (PGK) and Lactate dehydrogenase (LDH) are significantly up-regulated in HepG2 cells transfected by HBx comparing with control group. These findings suggest that HBV replication could alter host cell metabolism by increasing the rate of glycolysis to provide important metabolic requirements for nucleotides, amino acids and lipids synthesis. Hence, our proteomics approach may provide candidate biomarkers to improve the diagnosis of HBVrelated HCC patients.
Export Options
About this article
Cite this article as:
Sadrolodabaee Laleh, Low Keng Tiong, Feng Huixing and Chen Ning Wei, Role of HBV Replication in Host Cell Metabolism: A Proteomics Analysis, Current Proteomics 2013; 10 (1) . https://dx.doi.org/10.2174/15701646112099990008
DOI https://dx.doi.org/10.2174/15701646112099990008 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia
Current Medicinal Chemistry Radiolabeled Nucleoside Analogues for PET Imaging of HSV1-tk Gene Expression
Current Topics in Medicinal Chemistry The Immunomodulatory Potential of Selected Bioactive Plant-Based Compounds in Breast Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2
Current Drug Delivery Targeting Stem Cells-Clinical Implications for Cancer Therapy
Current Stem Cell Research & Therapy Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design
Current Pharmaceutical Design Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors
Current Radiopharmaceuticals Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells
Current Drug Targets Proresolution Mediators and Receptors: Novel Drug Targets for Enhancing Pharmacological Armamentarium against Periodontal Inflammation
Infectious Disorders - Drug Targets Therapeutic Potential of Photochemically Active Metal Complexes based on Interaction with Enzymes
Current Topics in Medicinal Chemistry Computational Approaches for Fragment-Based and De Novo Design
Current Topics in Medicinal Chemistry 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines
Current Medicinal Chemistry Defining the Role of Integrin αvβ6 in Cancer
Current Drug Targets Topoisomerase I and II Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Current Cancer Therapy Reviews New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design HCV-Related Transformation and New Therapeutic Strategies: An Update
Current Cancer Therapy Reviews